The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry
- PMID: 9370513
- PMCID: PMC1470341
- DOI: 10.1289/ehp.971051196
The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry
Abstract
A survey was performed on the results of 138 carcinogenicity studies conducted in various mouse strains by the agrochemical industry over the period 1983-1993. Data for liver tumor incidence, liver weight, and histopathology were collected along with data on genotoxicity. Studies were judged positive or negative for liver tumor formation on the basis of apparent dose response, malignancy, and difference from historical control values using a weight of evidence approach. Thirty-seven studies were judged to be positive for liver tumorigenicity in one or both sexes. There was no evidence showing an influence of the mouse strain and the duration of the study on the proportion of positive studies. Although 8 of the chemicals tested in the 138 studies were positive in the Ames test, only one of these was judged positive for carcinogenicity. Only 6 of the 37 positive chemicals had any other reported positive genotoxicity findings. A clear relationship between hepatomegaly at 1 year after exposure and a positive tumorigenic outcome at 18 months or 2 years after exposure was demonstrated. Whereas the average relative liver weight of top dose animals was 110% of control in negative studies, it was 150% in positive studies. Likewise, very few negative studies demonstrated significant pathological findings after 1 year, whereas the majority of positive studies had significant liver pathology. The implications of these findings for extrapolation to humans are discussed.
Similar articles
-
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.Mutat Res. 2006 Sep 19;608(1):29-42. doi: 10.1016/j.mrgentox.2006.04.017. Mutat Res. 2006. PMID: 16769241
-
Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).Natl Toxicol Program Tech Rep Ser. 1993 Nov;404:1-303. Natl Toxicol Program Tech Rep Ser. 1993. PMID: 12621514
-
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370. Natl Toxicol Program Tech Rep Ser. 1996. PMID: 12692653
-
The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists.Toxicol Pathol. 2002 Jan-Feb;30(1):147-56. doi: 10.1080/01926230252824860. Toxicol Pathol. 2002. PMID: 11890468 Review.
-
Liver tumor promoters and other mouse liver carcinogens.Prog Clin Biol Res. 1990;331:85-108. Prog Clin Biol Res. 1990. PMID: 2179967 Review.
Cited by
-
Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.J Toxicol Pathol. 2009 Mar;22(1):11-33. doi: 10.1293/tox.22.11. Epub 2009 Apr 6. J Toxicol Pathol. 2009. PMID: 22271974 Free PMC article.
-
Mechanisms of DNA-reactive and epigenetic chemical carcinogens: applications to carcinogenicity testing and risk assessment.Toxicol Res (Camb). 2018 Dec 18;8(2):123-145. doi: 10.1039/c8tx00250a. eCollection 2019 Mar 1. Toxicol Res (Camb). 2018. PMID: 30997017 Free PMC article. Review.
-
CD40 Receptor Knockout Protects against Microcystin-LR (MC-LR) Prolongation and Exacerbation of Dextran Sulfate Sodium (DSS)-Induced Colitis.Biomedicines. 2020 Jun 2;8(6):149. doi: 10.3390/biomedicines8060149. Biomedicines. 2020. PMID: 32498446 Free PMC article.
-
The p53 heterozygous knockout mouse as a model for chemical carcinogenesis in vascular tissue.Environ Health Perspect. 2000 Jan;108(1):61-5. doi: 10.1289/ehp.0010861. Environ Health Perspect. 2000. PMID: 10620525 Free PMC article.
-
Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties.Front Med (Lausanne). 2016 Oct 14;3:45. doi: 10.3389/fmed.2016.00045. eCollection 2016. Front Med (Lausanne). 2016. PMID: 27790617 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources